Core Viewpoint - Rayonier (RYN) shows potential for upside based on Wall Street analysts' short-term price targets, with a mean target of $27.2 indicating a 25.9% upside from the current price of $21.61 [1] Price Targets - The average price target consists of five estimates ranging from a low of $24.00 to a high of $33.00, with a standard deviation of $3.56, indicating variability among analysts [2] - The lowest estimate suggests an 11.1% increase, while the highest indicates a 52.7% upside [2] Analyst Consensus and Earnings Estimates - Analysts are increasingly optimistic about RYN's earnings prospects, as evidenced by a trend of higher EPS estimate revisions, which historically correlate with stock price movements [4][11] - Over the past 30 days, one estimate has increased, leading to a 1.2% rise in the Zacks Consensus Estimate for the current year [12] Zacks Rank - RYN holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, suggesting strong potential for upside [13] Price Target Reliability - While consensus price targets are a common metric, they should be approached with skepticism as they may not accurately predict stock price movements [3][10] - A low standard deviation among price targets indicates a high degree of agreement among analysts regarding the stock's price direction, serving as a starting point for further research [9]

Core Viewpoint - Contineum Therapeutics, Inc. (CTNM) shows significant upside potential with a mean price target of $21.83, indicating a 91.5% increase from the current trading price of $11.4 [1] Price Targets - The average price target consists of six estimates ranging from a low of $14.00 to a high of $29.00, with a standard deviation of $4.79, suggesting variability in analyst predictions [2] - The lowest estimate indicates a potential increase of 22.8%, while the highest suggests a 154.4% upside [2] Analyst Sentiment - Analysts are optimistic about CTNM's earnings prospects, with a consensus indicating better earnings than previously estimated, which historically correlates with stock price increases [4][11] - The Zacks Consensus Estimate for the current year has increased by 1.6% due to one upward revision in estimates over the last 30 days [12] Zacks Rank - CTNM holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13] Price Movement Insights - While consensus price targets may not be entirely reliable, the direction they imply appears to be a useful guide for potential price movements [14]

Core Viewpoint - nCino (NCNO) has shown a recent price increase of 6.4% and has a mean price target of $34.73, indicating a potential upside of 32.1% from its current price of $26.29 [1] Price Targets and Analyst Estimates - The mean estimate consists of 15 short-term price targets with a standard deviation of $4.08, suggesting variability in analyst predictions. The lowest estimate is $27.00 (2.7% increase), while the highest is $41.00 (56% increase) [2] - Analysts' price targets can be misleading, as empirical research indicates that they often do not accurately predict stock price movements [7][10] - A low standard deviation among price targets indicates strong agreement among analysts regarding the stock's price direction, which can serve as a starting point for further research [9] Earnings Estimates and Analyst Sentiment - Analysts have recently revised their earnings estimates for nCino upward, with a 55.1% increase in the Zacks Consensus Estimate for the current year, reflecting strong optimism about the company's earnings prospects [11][12] - nCino holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, which supports the potential for stock upside [13] Conclusion on Price Movement - While the consensus price target may not be a reliable measure of potential gains, the direction indicated by these targets appears to be a useful guide for investors [14]

Group 1 - AvePoint, Inc. (AVPT) shares have increased by 5.2% over the past four weeks, closing at $13.62, with a mean price target of $20 indicating a potential upside of 46.8% [1] - The mean estimate consists of 12 short-term price targets with a standard deviation of $4.07, where the lowest estimate is $16.00 (17.5% increase) and the highest is $28.00 (105.6% increase) [2] - Analysts show strong agreement on AVPT's ability to report better earnings, with a positive trend in earnings estimate revisions correlating with potential stock upside [4][11] Group 2 - The Zacks Consensus Estimate for the current year has risen by 12% over the past month, with one estimate increasing and no negative revisions [12] - AVPT holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting exact gains, they can indicate the direction of price movement, which is useful for further research [14]

Core Viewpoint - SailPoint, Inc. (SAIL) has seen a 12.9% increase in share price over the past four weeks, closing at $21.02, with analysts suggesting a potential upside to a mean price target of $26.39, indicating a 25.6% increase from the current price [1]. Price Targets and Analyst Consensus - The average price target consists of 21 estimates ranging from a low of $16.00 to a high of $31.70, with a standard deviation of $3.45, indicating variability among analysts [2]. - The lowest estimate suggests a decline of 23.9%, while the highest indicates a potential upside of 50.8% [2]. - Analysts' price targets can be misleading, as empirical research shows they often do not accurately predict stock price movements [7][10]. Earnings Estimates and Analyst Agreement - There is strong agreement among analysts regarding SAIL's ability to report better earnings, which supports the expectation of a stock price increase [4][11]. - Over the last 30 days, the Zacks Consensus Estimate for the current year has risen by 7.9%, with five estimates moving higher and no negative revisions [12]. - SAIL holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13]. Conclusion on Price Movement - While the consensus price target may not be a reliable indicator of the extent of potential gains, it does provide a useful guide for the direction of price movement [14].

Group 1 - Oddity Tech (ODD) shares have increased by 7.2% over the past four weeks, closing at $42.4, with a mean price target of $66.82 indicating a potential upside of 57.6% [1] - The mean estimate consists of 11 short-term price targets with a standard deviation of $12.63, where the lowest estimate is $46.00 (8.5% increase) and the highest is $80.00 (88.7% increase) [2] - Analysts show strong agreement on ODD's ability to report better earnings, with a positive trend in earnings estimate revisions correlating with potential stock price increases [4][11] Group 2 - The Zacks Consensus Estimate for ODD's current year has risen by 1.6% over the past month, with two estimates increasing and no negative revisions [12] - ODD holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for upside [13] - While consensus price targets may not be reliable for predicting exact gains, they can provide a directional guide for price movement [14]

Shares of Klarna (KLAR) have gained 8.4% over the past four weeks to close the last trading session at $30.48, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $46.06 indicates a potential upside of 51.1%.The mean estimate comprises 16 short-term price targets with a standard deviation of $3.7. While the lowest estimate of $39.00 indicates a 28% increase from the current price le ...

Core Viewpoint - Nuvation Bio Inc. (NUVB) has shown a significant price increase of 28.3% over the past four weeks, with a mean price target of $11.25 indicating a potential upside of 25.1% from the current trading price of $8.99 [1]. Price Targets and Analyst Consensus - The average price target consists of eight estimates ranging from a low of $8.00 to a high of $18.00, with a standard deviation of $2.96, indicating variability among analysts [2]. - The lowest estimate suggests an 11% decline from the current price, while the highest estimate indicates a potential upside of 100.2% [2]. - A low standard deviation signifies a high degree of agreement among analysts regarding the stock's price movement direction [9]. Earnings Estimates and Analyst Optimism - Analysts are increasingly optimistic about NUVB's earnings prospects, as evidenced by a positive trend in earnings estimate revisions [4][11]. - The Zacks Consensus Estimate for the current year has risen by 1.2% over the past month, with one estimate increasing and no negative revisions [12]. - NUVB holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13]. Caution on Price Targets - While price targets are commonly referenced by investors, they can often mislead and should not be the sole basis for investment decisions [3][7][10]. - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8].

Core Viewpoint - WisdomTree, Inc. (WT) has shown a 7.8% increase in stock price over the past four weeks, with a mean price target of $15.13 indicating a potential upside of 28.2% from the current price of $11.8 [1] Price Targets and Analyst Estimates - The mean estimate consists of six short-term price targets with a standard deviation of $1.5, where the lowest estimate is $13.25 (12.3% increase) and the highest is $17.00 (44.1% increase) [2] - A low standard deviation suggests a high degree of agreement among analysts regarding the stock's price movement, which can serve as a starting point for further research [9] Earnings Estimates and Analyst Sentiment - Analysts have shown increasing optimism about WT's earnings prospects, with a strong consensus in revising EPS estimates higher, which correlates with potential stock price increases [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 1%, with one estimate moving higher and no negative revisions [12] Zacks Rank and Investment Potential - WT currently holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for upside in the near term [13] - While the consensus price target may not be a reliable indicator of the extent of WT's gains, it does suggest a positive direction for price movement [14]

Core Viewpoint - Photronics (PLAB) shares have increased by 60.2% in the past four weeks, closing at $32.96, with a mean price target of $43.23 indicating a potential upside of 31.2% [1] Price Targets - The average price target consists of three estimates ranging from a low of $42.00 to a high of $45.00, with a standard deviation of $1.57, suggesting a potential increase of 27.4% to 36.5% from the current price [2] - A low standard deviation indicates a high degree of agreement among analysts regarding the price movement of PLAB [2][9] Analyst Sentiment - Analysts have shown increasing optimism about PLAB's earnings prospects, with a strong consensus in revising EPS estimates higher, which correlates with potential stock price increases [4][11] - Over the last 30 days, two earnings estimates have been revised upward, resulting in a 7.4% increase in the Zacks Consensus Estimate for the current year [12] Zacks Rank - PLAB holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13] Conclusion on Price Targets - While the consensus price target may not be a reliable measure of the extent of potential gains, it does provide a useful guide for the direction of price movement [14]